Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: "Misleading statement" ? lol. This statement has previously been

<PTSC responded that as of yet, there were no recurring royalty licenses signed.>

I do not believe that statement has been in Qs for many years. Why insert it in the last 10K? In any case, I view a contingent payment as different from recurring royalty payments. Perhaps my view is not correct.

Opty

Share
New Message
Please login to post a reply